SYFANTRIN

This brand name is authorized in Nigeria.

Active ingredients

The drug SYFANTRIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether
2	Lumefantrine UNII F38R0JR742 - LUMEFANTRINE
	Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100623	Tablet	Syfantrin 80 mg/ 480 mg Tablets TAB 80 mg; 480 mg 16, 112, 118, 124	7 NF-PP-346595 Syfantrin 80 mg/ 480 mg Tablets Artemether 80 mg and Lumefantrine 480 mg Artemether 80MG and Lumefantrin 480MG A4-100623 Drugs Imported Products 16, 112, 118, 124 Over The Counter (OTC) 9/1/2023 SYGEN PHARMACEUTICALS LIMITED, LAGOS ABEOKUTA EXPRESSWAY, OTA, OGUN STATE. OTA OGUN 7061286967 oluwatoyin.agbesuyi@sygenpharma.com GLOBELA PHARMA PVT LTD., 357,GIDC,Sachin,Surat, Gujarat, INDIA, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF01	Artemether and lumefantrine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100623